FFT Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.24M Sell
1,870
-5
-0.3% -$5.11K 0.35% 33
2026
Q1
$1.72M Buy
1,875
+1,541
+461% +$1.56M 0.31% 41
2025
Q4
$359K Sell
334
-1,535
-82% -$1.47M 0.07% 66
2025
Q3
$1.43M Hold
1,869
0.26% 40
2025
Q2
$1.2M Hold
1,869
0.24% 46
2025
Q1
$1.54M Buy
1,869
+1,398
+297% +$1.16M 0.32% 40
2024
Q4
$363K Sell
471
-62
-12% -$51.3K 0.03% 117
2024
Q3
$472K Buy
533
+310
+139% +$279K 0.04% 91
2024
Q2
$202K Buy
+223
New +$178K 0.02% 151
2021
Q4
Sell
-1,335
Closed -$309K 80
2021
Q3
$309K Buy
1,335
+18
+1% +$4.44K 0.03% 68
2021
Q2
$302K Buy
+1,317
New +$265K 0.07% 42

Other funds holding LLY

FFT Wealth Management's LLY Position: Q2 2026 in Review

FFT Wealth Management reduced its Eli Lilly (LLY) stake by 0.27% in Q2 2026, selling an estimated $5.11K and leaving 1,870 shares worth $2.24M. The position accounts for 0.35% of the portfolio, ranked #33.

FFT Wealth Management first reported a position in LLY in Q2 2021 and has held it in 11 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • FFT Wealth Management held 1,870 shares of Eli Lilly worth $2.24M as of Q2 2026.
  • FFT Wealth Management sold 5 Eli Lilly shares in Q2 2026, an estimated $5.11K.
  • Eli Lilly made up 0.35% of FFT Wealth Management's portfolio in Q2 2026, its #33 holding.
  • FFT Wealth Management first reported a position in Eli Lilly in Q2 2021 and has held it in 11 quarters since.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on FFT Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.